Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores
Journal of Gastrointestinal and Liver Diseases · 2026
DOI: 10.15403/jgld-7495 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2026. Verfasst von Abdulrahman Ismaiel und 9 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. abdulrahman.ismaiel@yahoo.com. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Liver Cirrhosis, Nutritional Status. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: Inflammatory bowel disease (IBD) requires reliable non-invasive biomarkers to monitor mucosal healing, systemic inflammation, and gut-liver axis involvement. This study evaluated the diagnostic potential of accessible clinical parameters, including fecal calprotectin (FC), hemogram-derived ratios, and composite albumin-integrating and liver fibrosis scores, alongside standardized endoscopic severity findings.
Methods
This retrospective observational study included 36 adult IBD patients [21 with Crohn’s disease (CD), 15 with ulcerative colitis (UC) receiving biological therapy. Systemic inflammatory indices [e.g., neutrophil-lymphocyte ratio (NLR)], nutritional scores [e.g. prognostic nutritional index (PNI)], and hepatic fibrosis scores [e.g. aspartate aminotransferase to platelet ratio index (APRI), fibrosis 4 (FIB-4), platelet-albumin-bilirubin (PALBI)] were assessed. Receiver operating characteristic (ROC) curve analysis evaluated the diagnostic performance, reported as area under the curve (AUC), of these biomarkers.
Results
Routine laboratory parameters and non-invasive liver fibrosis indices showed no statistically significant differences between CD and UC patients. Biologic treatment initiation differed significantly between the groups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 2nd Department of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. abdulrahman.ismaiel@yahoo.com.
- Faculty of medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. borlan_maya@yahoo.com.
- Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. dleucuta@umfcluj.ro.
- 2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. popa.stefan@umfcluj.ro.
- 2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. costinsimona_m@yahoo.com.
- 2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. dora_blaga@yahoo.com.
Zitieren
APA
Ismaiel, A., Borlan, M. Ș., Leucuta, D. C., Popa, S. L., Grad, S., Surdea-Blaga, T., Al Srouji, N., Abosheisha, M., Ismaiel, M., & Dumitrascu, D. I. (2026). Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-7495
Vancouver
Ismaiel A, Borlan MȘ, Leucuta DC, Popa SL, Grad S, Surdea-Blaga T, et al. Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores. Journal of Gastrointestinal and Liver Diseases. 2026. doi:10.15403/jgld-7495
BibTeX
@article{Ismaiel2026,
author = {Ismaiel, Abdulrahman and Borlan, Maya Ștefania and Leucuta, Daniel-Corneliu and Popa, Stefan-Lucian and Grad, Simona and Surdea-Blaga, Teodora and Al Srouji, Nahlah and Abosheisha, Mohamed and Ismaiel, Mohamed and Dumitrascu, Dinu Iuliu},
title = {Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2026},
doi = {10.15403/jgld-7495}
}
EUVIMED